BCTX BriaCell Therapeutics Corp

$BCTX very bullish, briacell mentioned in a merger as a "peer" comparator, trading at massive discount.

$BCTX 4.06 pre market?? Here’s the institutions being lazy in the new world of AI. That’s my theory. No body listened , at least with a brain anyway at a little roadshow. AI are not listening, just waiting for the transcript being printed then in a nano second interpretation. Yesterday should be market breaking news and turned BCTX from a high risk gamble into a timely investment opportunity. This lag is your chance imo . 1) science, check 2) fundamentals, on 9/29 taking dilution off the table on interim results. Check 3) technical, I can go into great detail, let’s put it this way it all adds up to a pre super golden cross trigger. Check ,check , check!!

$BCTX We are at Support in an upward trend. Today BioNTech failed in OS in head and neck cancer. Moderna will also fail in off shelf immunotherapy in OS. Will fail commercially In personalized neoantigen because of logistics and expense. Bria cell will be a dark horse with an off shelf platform that will be considered a medical miracle. Anyway that’s how I’m playing it and I added some more today at 3.78. The pre super golden cross is still in play.

$BCTX Yahoo Finance is showing a big drop in BCTX after hours but I'm not seeing that anywhere else or any news. Did someone sell 1 share at a discount or something??

$BCTX Highlights from today’s presentation 1. 144th event expected later this year. Data cleanup could take up to two months so the interim results could slip into 2027. 2. Next enrollment update will be enrollment completed, which is expected soon (within few months). 3. Cash not needed until Q2 2027 and the company is willing to stretch if needed to wait for interim results. Please add any new information you may have caught in the meeting.

$BCTX Patiently waiting for awareness of what we are holding. I have posted extensively on other boards and even got banned on the Moderna Reddit echo board of insanity. mRNA is being hyped as a cure for cancer yet the vaccine itself will fail commercially and is not the answer. Personalized Neo antigen mRNA is fine medical miracle except it’s logistically and financially impractical except for the few. The future is off shelf like the Bctx platform. Faster , cheaper and just as effective if not more so. We are just waiting for the proof . If/ when we are sitting on a moon shot.

$BCTX Seems nobody noticed the DHT comment from Williams... That correlated with survival...

$BCTX Excited to be here, I'm sure I left some things out: Awaiting Phase 3 results; primary endpoint is Overall Survival (OS) 80+ active clinical sites and growing Positive Phase 3 quality-of-life (QOL) data presented 7 positive DSMB reviews to date FDA Fast Track designation Strategic partnership with Fujifilm CEO William V. Williams spent 11 years as a VP at Incyte BriaCell partnered with Incyte for the use of retifanlimab with Bria-IMT Recognized by Nature Medicine as one of the “Eleven clinical trials that will shape medicine in 2026” AND don't forget BRIS-OTS 8.70M shares outstanding, with Phase 3 data potentially coming at any time Current market capitalization of only $36.63M Under $5 bucks...

$BCTX Upward channel intact. Either one (or maybe no) more up/downs before it breaks out big time to the upside.

$BCTX those who’ve been here longer than I have tell me why this can’t become $SLS 2.0? The event driven nature of the trading thesis seems very similar. Strong signal from phase 2. Well designed phase 3. Low float. Not saying the risk profiles are analogous but… SLS: DSMC has already seen unblinded Phase 3 efficacy/futility data and said continue. BCTX: DSMB has repeatedly reviewed Phase 3 safety and said continue, while efficacy remains blinded until the 144-event analysis. I get that early investors have been burned here. But for those of us looking to add now? Beyond murky financing and dilution history, what am I missing from a bear lens?

$BCTX Very likely Phase 3 data coming soon. The longer the data takes the more likely of Fast Track! Could turn into SOC. Huge Opportunity IMHO. Current Standard Of Care the 144 deaths would have occurred months ago potentially even late 2025. $NLY $BFRI

$BCTX if anyone has the time..read the $IMMU comments. It was a super bumpy road to a 20b+ BO…including a massive sell downgrade when the data was released…then after all retail sold in a panic due to the sell downgrade…they ran it up 10x+. Long story short…HODL your shares for a BO…no matter what nonsense they throw at us. If you own shares you must be drinking the same cool aid I drink & have faith…don’t give your shares away when positive data arrives. HODL for GODL 🌋

$BCTX was also wondering if we missed some additional news... but in alignment with the view this may be a delayed fuse to the data safety board PR. algo driven/short cover cycling for a small float...

$BCTX We'll have a few possibilities for news coming soon. Earnings next week (maybe), SITC poster presentation in November and the data wait continues.

$BCTX Big fat zero of shares to barrow since about 1pm yesterday. You can feel it you can hear it, getting near it 🎷🎷🎶 You want to make it because you can take it. 🎶🎷🎷🎶🙂🙃🙂🙃😎

$BCTX Friday websites should be updating on current short positions in stocks. So we should find out how big there position is and judging on the short volume over the last month I’m going to guess over 1 million shares short in this little float stock. I could be off to depending if some of them covered but I don’t think they have. Tick tock phase 3 coming. Bullish baby.

$BCTX Perhaps word is getting out that it works really, really well and doesn't have any side effects.

$BCTX Candel Therapeutics, the merger image company is in the same list as briacell in the 2026 Citeline Biotech Awards

$BCTX I really need some action on this ticker. Dont care if its 50% up or down, I'm just bored of looking at 4$ Give me 2$ and ill buy like crazy, or give me 6$ and I'm a happy man. Either goes wild for me 🤷🏼

$BCTX according to our AI friend, if we hit the 144 event in December a Monte Carlo simulation shows probability of success (hr<0.6) is virtually zero, if it hits in January it’s around 38% and February it’s around 78%. In sunnary, we really don’t want to hit this situation until next year, otherwise it’s highly probable that this will need to run through the full phase 3 and so we will require another sizable capital raise. If it’s going to take up to two months for the readout, then we should be hoping that we don’t hear anything until lateQ1 or even April next year. Just saying. We really don’t want to get anything this year - question is whether the share price runs up in advance of the readout, or if it runs out of steam and fear starts creeping as we head into 2027….